Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

21. A Simple Screening Tool to Predict Outcomes in Older Adults Undergoing Emergency General Surgery

A Simple Screening Tool to Predict Outcomes in Older Adults Undergoing Emergency General Surgery 30298686 2018 10 09 1532-5415 2018 Oct 09 Journal of the American Geriatrics Society J Am Geriatr Soc A Simple Screening Tool to Predict Outcomes in Older Adults Undergoing Emergency General Surgery. 10.1111/jgs.15627 To determine whether the Flemish version of the Triage Risk Screening Tool (fTRST) can be used to accurately assess frailty in an emergency setting. Prospective observational study (...) . of a tertiary referral hospital. All individuals aged 70 and older consecutively admitted to the emergency surgery unit with an urgent need for abdominal surgery between December 2015 and May 2016 who met inclusion criteria (N=110). Individuals were screened with the fTRST and additional metrics such as the age-adjusted Charlson Comorbidity Index and American Society of Anesthesiology score. Thirty- and 90-day postoperative complications where recorded. Regression analyses were performed to identify

EvidenceUpdates2018

22. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis

Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis 30326005 2018 10 19 2168-6114 2018 Oct 15 JAMA internal medicine JAMA Intern Med Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis. 10.1001/jamainternmed.2018.4637 Colorectal cancer screening (CRC) is recommended by all major US medical organizations but remains (...) underused. To identify interventions associated with increasing CRC screening rates and their effect sizes. PubMed, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, and ClinicalTrials.gov were searched from January 1, 1996, to August 31, 2017. Key search terms included colorectal cancer and screening. Randomized clinical trials of US-based interventions in clinical settings designed to improve CRC screening test completion in average-risk adults. At least 2 investigators

EvidenceUpdates2018

23. Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational prospective study of an Italian II level hospital

Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational prospective study of an Italian II level hospital 30288861 2018 10 17 1742-1241 2018 Oct 04 International journal of clinical practice Int. J. Clin. Pract. Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational (...) prospective study of an Italian II level hospital. e13281 10.1111/ijcp.13281 Reverse triage (RT) identifies patients eligible for discharge and have been proposed to cope with daily surge. Nevertheless, early discharge could increase the rate of readmission. Our aim is to test the effectiveness and safety of RT alone and with readmission screening tools (Identification Senior At Risk [ISAR], HOSPITAL, and Groeningen Frailty Index [GFI] scores) to predict appropriate discharge. We prospectively assessed

EvidenceUpdates2018

24. Dental radiograph as an opportunistic screening tool for a colorectal cancer syndrome (CAT#3342)

Dental radiograph as an opportunistic screening tool for a colorectal cancer syndrome (CAT#3342) UTCAT3342, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Dental radiograph as an opportunistic screening tool for a colorectal cancer syndrome Clinical Question Does dental radiograph serve as an opportunistic screening tool for early detection of extraintestinal manifestations of Familial Adenomatous Polyposis (FAP (...) ) in children and adults? Clinical Bottom Line Incidental findings on dental radiographs could serve as screening tools for systemic diseases and syndromes. The attention should be raised when gene mutation, congenitally diseases or familial colorectal cancer are reported by patients during the medical history questionnaire. For patients with risk of FAP, the Dental panoramic radiographic score (DPRS) is inexpensive, and reinforce the referral for the further clinical investigation, gene mapping

UTHSCSA Dental School CAT Library2018

25. Lung Cancer Screening

Lung Cancer Screening New 2018 ACR Appropriateness Criteria ® 1 Lung Cancer Screening American College of Radiology ACR Appropriateness Criteria ® Lung Cancer Screening Variant 1: Lung cancer screening. Patient 55 to 80 years of age and 30 or more packs per year smoking history and currently smoke or have quit within the past 15 years. Procedure Appropriateness Category Relative Radiation Level CT chest without IV contrast screening Usually Appropriate ??? CT chest with IV contrast Usually (...) Not Appropriate ??? CT chest without and with IV contrast Usually Not Appropriate ??? FDG-PET/CT skull base to mid-thigh Usually Not Appropriate ???? MRI chest without and with IV contrast Usually Not Appropriate O MRI chest without IV contrast Usually Not Appropriate O Radiography chest Usually Not Appropriate ? Variant 2: Lung cancer screening. Patient 50 years of age or older and 20 or more packs per year history of smoking and one additional risk factor (ie, radon exposure or occupational exposure

American College of Radiology2018

26. Screening for Perinatal Depression

Screening for Perinatal Depression INTERIM UPDATE ACOGCOMMITTEEOPINION Number 757 (Replaces Committee Opinion No. 630, May 2015) Committee on Obstetric Practice This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. INTERIM UPDATE: This Committee Opinion is updated as highlighted to reflect a limited, focused change in the language and supporting evidence regarding prevalence, benefits of screening, and screening tools (...) . Screening for Perinatal Depression ABSTRACT: Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects. Several screening instruments

American College of Obstetricians and Gynecologists2018

27. Are There Tools to Screen Children and Adolescents in the Emergency Department With Mental Health and Substance Abuse Issues?

Are There Tools to Screen Children and Adolescents in the Emergency Department With Mental Health and Substance Abuse Issues? Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Copyright © 2018 Inc. All rights reserved. | | | | | | The content on this site is intended for health professionals. We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the . Advertisements

Annals of Emergency Medicine Systematic Review Snapshots2018

28. Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions

Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions Final Recommendation Statement: Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 11/16/2018 6:27:19 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Unhealthy Alcohol Use (...) in Adolescents and Adults: Screening and Behavioral Counseling Interventions Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Adults 18 years or older, including pregnant women The USPSTF recommends screening for unhealthy alcohol use in primary care settings in adults 18

U.S. Preventive Services Task Force2018

29. Leading Women's Health Care Groups Issue Joint Statement on USPSTF Final Cervical Cancer Screening Recommendations

Leading Women's Health Care Groups Issue Joint Statement on USPSTF Final Cervical Cancer Screening Recommendations

Society of Gynecologic Oncology2018

30. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review

Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review 30367972 2018 11 16 1096-0260 118 2018 Oct 24 Preventive medicine Prev Med Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review. 113-121 S0091-7435(18)30340-2 10.1016/j.ypmed.2018.10.021 Despite clear evidence that colorectal cancer (CRC) screening reduces mortality, screening, including fecal (...) immunochemical tests (FIT), is underutilized. We conducted a systematic review to determine the evidence of efficacy of interventions to improve FIT completion that could be scaled and utilized in population health management. We systematically searched publication databases for studies evaluating provider- or system-level interventions to improve CRC screening by FIT between 1 January 1996 and 13 December 2017 without language restrictions. Twenty articles describing 25 studies were included, 23 were

EvidenceUpdates2018

31. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems

In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems 30268859 2018 11 05 1879-2472 171 2018 Sep 19 Thrombosis research Thromb. Res. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care (...) systems. 97-102 S0049-3848(18)30534-6 10.1016/j.thromres.2018.09.050 Unprovoked venous thromboembolism (VTE) may be the first manifestation of an undiagnosed cancer. We assessed the cost-effectiveness of 18 F-Fluorodesoxyglucose Positron Emission/Computed Tomography (FDG PET/CT) plus limited screening and limited screening strategies in patients with unprovoked VTE from the perspectives of the Ontario (Canada) and French health care systems. We conducted a cost-effectiveness analysis based

EvidenceUpdates2018

32. Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?

Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer? 30426972 2018 12 07 2059-7029 3 6 2018 ESMO open ESMO Open Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer? e000449 10.1136/esmoopen-2018-000449 Bossi Paolo P Head and Neck Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. eng Journal Article 2018 10 24 England ESMO Open 101690685 2059-7029 nutrition

ESMO open2018 Full Text: Link to full Text with Trip Pro

33. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. Importance: Intimate partner violence (IPV), elder abuse, and abuse of vulnerable adults are common and result in adverse health outcomes. Objective: To review the evidence on screening and interventions for IPV, elder abuse, and abuse of vulnerable adults to inform the US Preventive Services Task Force. Data Sources: MEDLINE (...) of heterogeneity of populations, interventions, and outcomes. Main Outcomes and Measures: Abuse or neglect, morbidity caused by abuse, test accuracy, and harms. Results: Thirty studies were included (N = 14 959). Three RCTs (n = 3759) compared IPV screening with no screening; none found significant improvements in outcomes (eg, IPV or quality of life) over 3 to 18 months and 2 (n = 935) reported no harms of screening. Nine studies assessed tools to detect any past-year or current IPV in women; for past-year

JAMA2018

34. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement.

Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement. Importance: Intimate partner violence (IPV) and abuse of older or vulnerable adults are common in the United States but often remain undetected. In addition to the immediate effects of IPV, such as injury and death, there are other health consequences, many with long-term effects, including development of mental health conditions (...) such as depression, posttraumatic stress disorder, anxiety disorders, substance abuse, and suicidal behavior; sexually transmitted infections; unintended pregnancy; and chronic pain and other disabilities. Long-term negative health effects from elder abuse include death, higher risk of nursing home placement, and adverse psychological consequences. Objective: To update the US Preventive Services Task Force (USPSTF) 2013 recommendation on screening for IPV, elder abuse, and abuse of vulnerable adults. Evidence

JAMA2018

35. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.

Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study. Background: Short-term studies have reported that the fecal immunochemical test (FIT) is less accurate in detecting proximal than distal colorectal neoplasia. Objective: To assess the long-term detection rates for advanced adenoma and colorectal cancer (CRC), according to anatomical location. Design: Retrospective study. Setting: Population (...) -based, organized screening program in the Veneto region of Italy. Participants: Persons aged 50 to 69 years who completed 6 rounds of FIT screening. Measurements: At each screening round, the detection rates for advanced adenoma and cancer, as well as the proportional interval cancer rate (PICR), were calculated by anatomical location (proximal colon, distal colon, or rectum). Results: Between 2002 and 2014, a total of 123 347 participants had 441 647 FITs. The numbers of advanced adenomas

Annals of Internal Medicine2018

36. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Breast cancer will develop in 12% of women during their lifetime and is the second leading cause of cancer death among U.S. women. Mammography is the most commonly used tool to screen for breast cancer. Considerable uncertainty exists regarding the age at which to begin screening and the optimal screening interval. Breast density is a risk factor (...) for breast cancer. In addition, for women with dense breasts, small tumors may be missed on mammography and the sensitivity of screening is diminished. At the time of publication, 35 states had passed laws mandating that breast density be reported in the letters that radiologists send to women with their mammogram results. The mandated language may be challenging for patients to understand, and such reporting may increase worry for women who are told that their risk for breast cancer is higher than

Annals of Internal Medicine2018

37. Practice Advisory: Cervical Cancer Screening

Practice Advisory: Cervical Cancer Screening Practice Advisory: Cervical Cancer Screening - ACOG Menu ▼ Practice Advisory: Cervical Cancer Screening Page Navigation ▼ Share: Practice Advisory: Cervical Cancer Screening On September 12, 2017, the U.S. Preventive Services Task Force (USPSTF) released its . The draft recommendations for average-risk women are listed in the following table. The major proposed change from the previous USPSTF recommendations is that for average-risk women aged 30–65 (...) years, screening with high-risk HPV testing alone is recommended as an alternative to cervical cytology alone, and cotesting is no longer recommended. In contrast, (1) from the American College of Obstetricians and Gynecologists (ACOG) recommend that for average-risk women aged 30–65 years, co-testing with cervical cytology and high-risk HPV testing every 5 years is the preferred approach, with cervical cytology alone every 3 years as an acceptable screening strategy. Current ACOG guidance does

American College of Obstetricians and Gynecologists2018

38. Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis

Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis 29964000 2018 10 02 1532-821X 99 10 2018 Oct Archives of physical medicine and rehabilitation Arch Phys Med Rehabil Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis. 2045-2049 S0003-9993(18)30390-3 10.1016/j.apmr.2018.05.029 To assess the diagnostic and clinical utility of the 2-item Generalized Anxiety Disorder (...) Scale (GAD-2) for screening anxiety symptoms in individuals with multiple sclerosis (MS). Cross-sectional. University-affiliated MS neurology and rehabilitation center. The sample comprised adults (N=99) (ages 19-72; mean ± SD=46.2±13.0; 75% women) with a physician-confirmed MS diagnosis who were receiving care in a university-affiliated MS center. Disease durations ranged from 1 to 37 years (mean ± SD=10.7±8.4). Not applicable. Participants completed the 7-item Generalized Anxiety Disorder Scale

EvidenceUpdates2018

39. Examining Balloon Expulsion Testing as an Office-Based, Screening Test for Dyssynergic Defecation: A Systematic Review and Meta-Analysis

Examining Balloon Expulsion Testing as an Office-Based, Screening Test for Dyssynergic Defecation: A Systematic Review and Meta-Analysis 30171220 2018 09 01 1572-0241 2018 Aug 31 The American journal of gastroenterology Am. J. Gastroenterol. Examining Balloon Expulsion Testing as an Office-Based, Screening Test for Dyssynergic Defecation: A Systematic Review and Meta-Analysis. 10.1038/s41395-018-0230-5 Balloon expulsion testing (BET) is recommended to evaluate for dyssynergic defecation (...) affected by varying the maximum allowed expulsion time between 1 to 5 min. Age and gender likely accounted for significant study heterogeneity between studies. Choice of reference test, continent of study, and year of study did not significantly affect test performance. We report an optimized BET protocol. The performance characteristics of BET could support its use as a point of service test to screen for dyssynergic defecation in chronically constipated subjects. Shah Eric D ED Division

EvidenceUpdates2018

40. Canadian guideline on genetic screening for hereditary renal cell cancers

Canadian guideline on genetic screening for hereditary renal cell cancers CUAJ • September-October 2013 • Volume 7, Issues 9-10 © 2013 Canadian Urological Association 319 CLINICAL PRACTICE GUIDELINE 1 Division of Medical Oncology, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, ON; 2 Eastern Ontario Regional Genetics Program, Children’s Hospital of Eastern Ontario and the University of Ottawa, Ottawa, ON; 3 Molecular Diagnostics, Department of Pathology, The University (...) for the Kidney Cancer Research Network of Canada Canadian guideline on genetic screening for hereditary renal cell cancersCUAJ • September-October 2013 • Volume 7, Issues 9-10 320 Reaume et al. or saliva) to determine inherited predisposition to specific cancers. Ideal tumour sites for germline genetic profiling have high penetrance mutations that translate into clinical utility, meaning they inform clinical decision-making and facilitate the prevention or amelioration of adverse health outcomes. Hereditary

Canadian Urological Association2018